0.0001
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Luis Manuel Ornelas Lopez | Chairman, CEO, President & COO | -- | -- | -- |
| Mr. Barry W. Hall | Interim Chief Financial Officer | -- | -- | 1948 |
PharmaRoth Labs, Inc.
8250 West Charleston Boulevard
Suite 120
Las Vegas, NV 89117
United States
- Sector:
- Healthcare
- Industry: Biotechnology
Description
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.
Corporate Governance
PharmaRoth Labs, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available